mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.009 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.009 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |